Research Peptides for Female Physiology: Compounds Studied in Hormonal Cycling, Collagen, and Reproductive Biology

Sex-disaggregated research design has become increasingly standard in biomedical literature following NIH requirements for including female subjects in preclinical studies after 2016. This shift has generated a growing body of data specifically examining how peptide compounds behave in female rodent models, female human cell lines, and female clinical cohorts. The patterns that have emerged across several research categories are worth noting for researchers designing female-physiology studies.

In reproductive endocrinology, kisspeptin occupies a central role because the KISS1/KISS1R system governs GnRH pulsatility in both sexes but with sex-specific regulatory inputs. In female models, kisspeptin neurons in the anteroventral periventricular nucleus are regulated by estrogen in a positive feedback configuration during the pre-ovulatory LH surge, while the arcuate nucleus kisspeptin population serves negative feedback. This architectural complexity makes kisspeptin a particularly valuable research tool in cycle models, hypothalamic amenorrhea investigations, and studies of stress-suppressed reproductive function.

Skin collagen research has long recognized female-specific dynamics. Estrogen receptors are expressed in dermal fibroblasts, and estrogen status influences baseline collagen synthetic rates in ways that make post-menopausal skin biology an active research area. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) stimulates fibroblast collagen production through a mechanism independent of estrogen signaling, documented in Pickart et al. (PMID 17572687) and earlier by Maquart and colleagues. The published wound-model data suggests GHK-Cu remains active in aged and estrogen-depleted skin preparations, making it relevant to research spanning reproductive life stage transitions.

BPC-157 has been evaluated in numerous tissue repair models including studies relevant to hormonal variation on healing responses. The cytoprotective and angiogenic properties documented by Sikiric et al. (PMID 26139110) have been observed across multiple tissue types and biological sex conditions. Researchers interested in exercise recovery, musculoskeletal biology, and connective tissue repair in female athlete or female aging models have cited this compound's multi-tissue activity as a research advantage.

NAD+ occupies a different position in female physiology research. Gomes et al. (PMID 24270807) established that declining NAD+ disrupts the SIRT1-HIF-1alpha axis in aging, producing pseudo-hypoxic mitochondrial dysfunction independent of sex. But subsequent research has explored sex-specific NAD+ metabolism, including the role of estrogen in regulating NAMPT expression (a rate-limiting enzyme in NAD+ biosynthesis). Researchers examining perimenopause, ovarian aging, and mitochondrial function in female aging models have a growing body of literature to draw from.

Researchers designing studies in female physiology should note that these compounds address distinct mechanistic layers: reproductive axis signaling (kisspeptin, PT-141), structural extracellular matrix biology (GHK-Cu), tissue repair and cytoprotection (BPC-157), and cellular energy metabolism (NAD+). A study design requiring coverage across multiple physiological axes will need to address each layer independently, as the compounds do not share mechanisms or interact at documented biological targets.